← Company directory
Psyomics
About
Pioneering a new era in precision mental health
Through digital and biological data, backed by science and developed by clinicians, beseen™ exists to give people a trusted place to share their mental health story, whilst driving clinical productivity and administrative efficiency.
The Psyomics family of solutions:
- beseen™ Adult is developed with clinicians and users to enhance the patient journey by delivering structured data and rich free text, whenever and wherever you need it in the pathway.
- beseen™ Young People combines input from children, families and professionals into one structured report – creating the foundation for consistent, integrated care from the very first contact.
- beseen™ Neurodiversity is a systematic and needs-led solution.
- It standardises and captures information clinicians rely on, when they need it.
- Bipolar Biomarker is being developed in conjunction with the University of Cambridge.
- Psyomics is leading the field on research into precision diagnosis for Bipolar Disorder through combining digital and biological insights.
Successes in UK/NHS
Psyomics is part of the NHS Innovation Accelerator (NIA 2025) and was a finalist for digital innovation in the HTN 2025 and HSJ 2024 for its work across the NHS and private sectors.
Currently covering 6 million lives in England.
Organisation details
Website
www.psyomics.com/ ↗Revenue
£0-2m
Funding Status
Series A
Desired Markets
US and Middle East
Specialism